Immunovant (IMVT) Enterprise Value Growth (1y) (2020 - 2026)
Immunovant (IMVT) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Immunovant |
5.71 Bn |
5.71 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.35% |
| Dec 31, 2025 |
-165.42% |
| Sep 30, 2025 |
-10.35% |
| Jun 30, 2025 |
-6.95% |
| Mar 31, 2025 |
-12.37% |
| Dec 31, 2024 |
45.77% |
| Sep 30, 2024 |
-75.21% |
| Jun 30, 2024 |
-69.72% |
| Mar 31, 2024 |
-68.74% |
| Dec 31, 2023 |
-59.71% |
| Sep 30, 2023 |
33.48% |
| Jun 30, 2023 |
22.76% |
| Mar 31, 2023 |
23.75% |
| Dec 31, 2022 |
17.91% |
| Sep 30, 2022 |
27.40% |
| Jun 30, 2022 |
-12.72% |
| Dec 31, 2021 |
-24.88% |
| Sep 30, 2021 |
-25.78% |
| Jun 30, 2021 |
-35.21% |
| Sep 30, 2020 |
-27,496.49% |
